AG Pulmonale Hypertonie (PH)

Reversed valved Potts shunt for refractory primary pulmonary arterial hypertension. Michel S, Pattathu J, Hörer J, Kari FA.  Multimed Man Cardiothorac Surg. 2025 Jan 16;2025. doi: 10.1510/mmcts.2024.120.

Fontan Circulation and Aortic Stiffness: Insights into Vascular Dynamics and Haemodynamic Interplay. Walser M, Arnold L, Mandilaras G, Funk C, Dalla-Pozza R, Pattathu J, Haas NA, Jakob A. Pediatr Cardiol. 2024 Jul 15. doi: 10.1007/s00246-024-03572-z.

Familiar Disposition of May-Thurner Syndrome-A Case Series. Nowak S, Jakob A, Dalla Pozza R, Michel S, Haas NA, Pattathu J. Life (Basel). 2024 Feb 4;14(2):221. doi: 10.3390/life14020221.

Case report: Beneficial long-term effect of the atrial-flow-regulator device in a pediatric patient with idiopathic pulmonary arterial hypertension and recurring syncope. Pattathu J, Michel S, Tengler A, Mandilaras G, Jakob A, Dalla-Pozza R, Haas N. Frontiers in Cardiovascular Medicine 2023, 10. https://doi.org/10.3389/fcvm.2023.1197985

Case report: Paracorporeal lung assist device for 215 days as a bridge-to-lung transplantation in a patient with bronchopulmonary dysplasia and severe pulmonary hypertension. Michel S, Hanuna M, Pattathu J, Pabst von Ohain J, Schneider C, Kauke T, Kneidinger N, Behr J, Milger K, Barton J, Veit T, Kamla C, Mueller C, Dzieciol R, Christen L, Irlbeck M, Tomasi R, Abicht J, Scheiermann P, Feuerecker M, Dalla-Pozza R, Fischer M, Jakob A, Hermann M, Haas N, Hagl C, Hörer J. Frontiers in Transplantation 2023, 2. https://doi.org/10.3389/frtra.2023.1197906

Evaluation of the diagnostic and prognostic potential of optical coherence tomography (OCT) of the pulmonary arteries during standardised right heart catheterisation in patients with pulmonary hypertension: a cross-sectional single-centre experience. Zeiger E, Jakob A, Dalla Pozza R, Fischer M, Tengler A, Ulrich SM, Arnold L, Weismann CG, Schulze-Neick I, Haas NA, Pattathu J. Cardiovasc Diagn Ther 2023; 13(3):453-464. doi: 10.21037/cdt-22-421

Case report: Central venous catheter thrombosis complicated by chronic thromboembolic disease/pulmonary hypertension in two children requiring parenteral nutrition. Hanuna M, Pattathu J, Buech J, Kamla C, Kneidinger N, Behr J, Milger K, Veit T, Nagel N, Abicht J, Dalla-Pozza R, Fischer M, Jakob A, Hermann M, Schramm R, Rosenthal L, Haas N, Hörer J, Hagl C, Michel S. Frontiers in Cardiovascular Medicine 2023, 10. https://doi.org/10.3389/fcvm.2023.1198204 

Riociguat in children with pulmonary arterial hypertension: The PATENT–CHILD study. Aguilar H, Gorenflo M, Dunbar Ivy D, Moledina S, Castaldi B, Ishida H, Cześniewicz P, Kusa J, Miera O, Pattathu J, Weng KP, Ablonczy L, Apitz C, Katona M, Kurosaki K, Pulido T, Yamagishi H, Yasuda K, Cisternas G, Goth M, Lippert S, Radomskyj A, Saleh S, Willmann S, Wirsching G, Bonnet D, Beghetti M. Pulmonary Circulation 2022, 12(3). https://doi.org/10.1002/pul2.12133

Successful intravascular pulmonary lithotripsy in a child with chronic thromboembolic pulmonary hypertension. Pediatr Pulmonol. Diepenbruck S, Dalla-Pozza R, Pattathu J, Haas N, Jakob A.  2021 Jun;56(6):1690-1693. doi: 10.1002/ppul.25338.

Neue hämodynamische Definition der pulmonalen Hypertonie: Kommentar der Arbeitsgemeinschaft Pulmonale Hypertonie der Deutschen Gesellschaft für Pädiatrische Kardiologie und angeborene Herzfehler e. V. (DGPK). Pitz C, Abdul-Khaliq H, Albini S, Beerbaum P, Dubowy KO, Gorenflo M, Hager A, Hansmann G, Hilgendorff A, Humpl T, Kaestner M, Koestenberger M, Kozlik-Feldmann R, Latus H, Michel-Behnke I, Miera O, Quandt D, Sallmon H, Schranz D, Schulze-Neick I, Stiller B, Warnecke G, Pattathu J, Lammers AE. Monatsschr Kinderheilkd 168, 252–256 (2020). https://doi.org/10.1007/s00112-019-00792-z

Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Hansmann G, Apitz C, Abdul-Khaliq H, Alastalo TP, Beerbaum P, Bonnet D, Dubowy K-O, Gorenflo M, Hager A, Hilgendorff A, Kaestner M, Koestenberger M, Koskenvuo J, Kozlik-Feldmann R, Kuehne T, Lammers A, Latus H, Michel-Behnke I, Miera O, Moledina S, Muthurangu V, Pattathu J, Schranz D, Warnecke G, Zartner P. Heart 2016;102: 86-100. https://doi.org/10.1136/heartjnl-2015-309132

Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Pattathu J, Gorenflo M, Hilgendorff A, Koskenvuo J, Apitz C, Hansmann G, Alastalo T-P. Heart British Cardiac Society, Heart 2016;102:ii36-ii41. https://doi.org/10.1136/heartjnl-2014-307238

Pulmonary Hypertension in paediatric patients: data from the compera-kids registry. Gorenflo M, Pittrow D, Huscher D, Ziesenitz V, Pattathu J, Praus A, Ewert P, Kaemmerer H, COMPERA-Kids Steering Committee Study Group. Thorac Cardiovasc Surg 2015; 63 - V0001. DOI: 10.1055/s-0035-1555958. Conference Paper

Die primären Studienziele sind die Untersuchung der Sicherheit und Verträglichkeit sowie der Pharmakokinetik (PK) von Sotatercept über einen Behandlungszeitraum von 24 Wochen bei Kindern im Alter von ≥1 bis <18 Jahren mit PAH der Weltgesundheitsorganisation (WHO)-Gruppe 1 unter Standardtherapie (SoC).